The decrease in BMI due to metformin or lifestyle intervention, which resulted in decreased insulin resistance and increased adiponectin concentration, accounted for a varying degree of change in some of the lipoprotein measures. The gene discussed is ADIPOQ; the disease is Insulin resistance.